Microcrystalline cellulose (MCC) is a widely used excipient in tablet manufacturing, serving primarily as a binder and filler [1]. Its physical properties make it ideal for creating compact and stable tablets [1].
Why is Microcrystalline Cellulose Good for Tablets?
MCC's effectiveness in tablets stems from its unique characteristics. It exhibits excellent compressibility, meaning it can be pressed under high pressure to form solid, uniform tablets [2]. This property is crucial for ensuring tablets maintain their shape and integrity during handling and packaging [2]. MCC also has good flow properties, allowing it to move consistently through the tablet manufacturing equipment [1]. Furthermore, it is relatively inert, meaning it does not react with the active pharmaceutical ingredient (API) or other excipients in the tablet formulation, thus preserving the drug's stability and efficacy [1].
What Other Roles Does Microcrystalline Cellulose Play in Tablets?
Beyond binding and filling, MCC can also act as a disintegrant in some tablet formulations [3]. Disintegrants are essential for helping tablets break apart quickly when they come into contact with bodily fluids, facilitating drug release and absorption [3]. While its primary function is mechanical support, its inherent properties can contribute to faster disintegration depending on the specific formulation and compression forces used [3].
How Does Microcrystalline Cellulose Compare to Other Tablet Binders?
Compared to other common binders like starch or lactose, MCC offers superior compressibility and tablet hardness [1]. Starch, for instance, is a good binder but can be prone to moisture absorption, potentially affecting tablet stability [1]. Lactose is also a common filler and binder, but it can have poor compressibility, leading to weaker tablets, and may not be suitable for lactose-intolerant patients [1]. MCC's low moisture content and good compactibility generally make it a preferred choice for direct compression tablet manufacturing, a method that simplifies the production process [1].
Can Microcrystalline Cellulose Affect Drug Release?
While MCC is primarily a structural component, its physical form and the degree of compression can influence drug release profiles [4]. Highly compressed tablets with MCC may exhibit slower disintegration and thus slower drug release. Conversely, formulations designed for rapid release might use MCC in combination with effective disintegrants or at lower compression forces [4]. The interaction between MCC, the API, and other excipients is a critical consideration during formulation development to achieve the desired pharmacokinetic outcome [4].